318 related articles for article (PubMed ID: 30279734)
1. Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.
Wang Q; Cai J; Fang C; Yang C; Zhou J; Tan Y; Wang Y; Li Y; Meng X; Zhao K; Yi K; Zhang S; Zhang J; Jiang C; Zhang J; Kang C
Theranostics; 2018; 8(17):4733-4749. PubMed ID: 30279734
[No Abstract] [Full Text] [Related]
2. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
3. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
[TBL] [Abstract][Full Text] [Related]
4. miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas.
Ho KH; Chen PH; Shih CM; Lee YT; Cheng CH; Liu AJ; Lee CC; Chen KC
Cell Mol Neurobiol; 2022 Apr; 42(3):791-806. PubMed ID: 33025417
[TBL] [Abstract][Full Text] [Related]
5. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract][Full Text] [Related]
7. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
[TBL] [Abstract][Full Text] [Related]
8. FZD1/KLF10-hsa-miR-4762-5p/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report.
Jia F; Zhang L; Jiang Z; Tan G; Wang Z
BMC Med Genomics; 2023 Feb; 16(1):21. PubMed ID: 36755291
[TBL] [Abstract][Full Text] [Related]
9. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
[TBL] [Abstract][Full Text] [Related]
10. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
[TBL] [Abstract][Full Text] [Related]
11. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
12. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Chiu YC; Hsiao TH; Chen Y; Chuang EY
BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
[TBL] [Abstract][Full Text] [Related]
13. TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma.
Xie Y; Chen L; Zhou J; Yang C; Xu C; Fan X; Tan Y; Wang Y; Kang C; Fang C
Cancer Biol Med; 2020 Aug; 17(3):664-675. PubMed ID: 32944398
[No Abstract] [Full Text] [Related]
14. Comprehensive analysis of ceRNA network related to lincRNA in glioblastoma and prediction of clinical prognosis.
Liu G; Liu D; Huang J; Li J; Wang C; Liu G; Ge S; Gong H
BMC Cancer; 2021 Jan; 21(1):98. PubMed ID: 33499813
[TBL] [Abstract][Full Text] [Related]
15. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
16. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
Li Q; Yu Q; Ji J; Wang P; Li D
Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
[TBL] [Abstract][Full Text] [Related]
17. The LGMN pseudogene promotes tumor progression by acting as a miR-495-3p sponge in glioblastoma.
Liao K; Qian Z; Zhang S; Chen B; Li Z; Huang R; Cheng L; Wang T; Yang R; Lan J; Lu X; Kong L; Song X; Qiu Y; Lin Y
Cancer Lett; 2020 Oct; 490():111-123. PubMed ID: 32711096
[TBL] [Abstract][Full Text] [Related]
18. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma.
Wang X; Liu S; Shao Z; Zhang P
Mol Med Rep; 2020 Aug; 22(2):1362-1372. PubMed ID: 32626960
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
